|
1
|
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
|
JAMA
|
2010
|
5.06
|
|
2
|
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials.
|
J Am Coll Cardiol
|
2013
|
2.99
|
|
3
|
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials.
|
Arch Neurol
|
2010
|
2.83
|
|
4
|
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.
|
J Hypertens
|
2014
|
2.28
|
|
5
|
Evidence of pre-procedural statin therapy a meta-analysis of randomized trials.
|
J Am Coll Cardiol
|
2010
|
1.76
|
|
6
|
Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines.
|
J Am Coll Cardiol
|
2011
|
1.62
|
|
7
|
Limitations of the MEDLINE database in constructing meta-analyses.
|
Ann Intern Med
|
2010
|
1.48
|
|
8
|
Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative.
|
Hypertension
|
2012
|
1.46
|
|
9
|
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials.
|
J Hypertens
|
2014
|
1.45
|
|
10
|
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
1.41
|
|
11
|
Aspiration thrombectomy in patients undergoing primary angioplasty: totality of data to 2013.
|
Catheter Cardiovasc Interv
|
2014
|
1.33
|
|
12
|
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
|
Am J Med
|
2010
|
1.17
|
|
13
|
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
|
J Interv Cardiol
|
2010
|
1.14
|
|
14
|
Development of coronary aneurysm after drug-eluting stent implantation.
|
Ann Intern Med
|
2007
|
1.14
|
|
15
|
Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.
|
Am J Med
|
2009
|
1.07
|
|
16
|
Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials.
|
Am Heart J
|
2011
|
1.04
|
|
17
|
Is clopidogrel cardiovascular medicine's double-edged sword?
|
Circulation
|
2006
|
1.01
|
|
18
|
Silent ischemia: clinical relevance.
|
J Am Coll Cardiol
|
2012
|
0.99
|
|
19
|
The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.
|
Am Heart J
|
2008
|
0.91
|
|
20
|
A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis.
|
Am J Cardiol
|
2006
|
0.89
|
|
21
|
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.
|
Am J Cardiovasc Drugs
|
2007
|
0.89
|
|
22
|
Fractional flow reserve: an updated review.
|
Clin Cardiol
|
2014
|
0.87
|
|
23
|
The association between NSAID use and colorectal cancer mortality: results from the women's health initiative.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
0.86
|
|
24
|
Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
|
Am J Cardiol
|
2007
|
0.85
|
|
25
|
Presence of carotid and peripheral arterial disease in patients with left main disease.
|
Am J Cardiol
|
2007
|
0.84
|
|
26
|
Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events.
|
Cleve Clin J Med
|
2013
|
0.83
|
|
27
|
Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women's Health Initiative [WHI]).
|
Am J Cardiol
|
2012
|
0.83
|
|
28
|
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention.
|
Am J Cardiol
|
2012
|
0.82
|
|
29
|
Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention?
|
J Am Coll Cardiol
|
2016
|
0.82
|
|
30
|
Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines.
|
Clin Cardiol
|
2011
|
0.81
|
|
31
|
Acute coronary syndrome (unstable angina and non-ST elevation MI).
|
BMJ Clin Evid
|
2009
|
0.80
|
|
32
|
Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents.
|
Am Heart J
|
2008
|
0.79
|
|
33
|
The optimal treatment of carotid atherosclerosis: a 2008 update and literature review.
|
Postgrad Med
|
2008
|
0.79
|
|
34
|
Drug-eluting stents: dual antiplatelet therapy for every survivor?
|
Circulation
|
2007
|
0.77
|
|
35
|
Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials.
|
Catheter Cardiovasc Interv
|
2014
|
0.77
|
|
36
|
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.
|
Am J Cardiol
|
2006
|
0.76
|
|
37
|
Non ST-elevation acute coronary syndrome.
|
BMJ Clin Evid
|
2010
|
0.75
|
|
38
|
Routine vs selective invasive strategies in acute coronary syndromes.
|
JAMA
|
2005
|
0.75
|
|
39
|
Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint?
|
Am Heart J
|
2007
|
0.75
|
|
40
|
Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.
|
PLoS One
|
2016
|
0.75
|
|
41
|
Designing the ideal risk model for acute coronary syndromes--is simple better than complex?
|
Am Heart J
|
2007
|
0.75
|
|
42
|
Possible benefit to survival from early invasive strategies in patients with acute coronary syndromes.
|
Ann Intern Med
|
2008
|
0.75
|
|
43
|
Reply: aspiration thrombectomy: an easily forgiven "latecomer".
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
44
|
Images in Cardiovascular Medicine. Don't turn your head!
|
Circulation
|
2009
|
0.75
|
|
45
|
Treatment of hypertension: lower is better, or is it?
|
Hypertension
|
2012
|
0.75
|
|
46
|
Paving the coronaries with stents: okay in acute coronary syndromes?
|
Clin Cardiol
|
2011
|
0.75
|
|
47
|
Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization.
|
Tex Heart Inst J
|
2015
|
0.75
|
|
48
|
Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
|
Am J Cardiol
|
2006
|
0.75
|
|
49
|
Acute myocardial infarction.
|
Am J Med
|
2005
|
0.75
|
|
50
|
Acute myocardial infarction during infusion of liposomal doxorubicin for recurrent breast cancer.
|
Breast J
|
2010
|
0.75
|
|
51
|
Drug-eluting stents: can we move beyond stent thrombosis?
|
Am Heart Hosp J
|
2007
|
0.75
|
|
52
|
Understanding and minimizing late thrombosis of drug-eluting stents.
|
Cleve Clin J Med
|
2007
|
0.75
|
|
53
|
Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
|
Indian Heart J
|
2009
|
0.75
|
|
54
|
Reply: Mechanical Thrombectomy for Ischemic Stroke.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
55
|
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness.
|
Am Surg
|
2015
|
0.75
|
|
56
|
Reply: Meta-Analysis of Strategies for Patients With Multivessel Disease Undergoing Percutaneous Coronary Intervention: Does the Timing of Staged Procedures Matter?
|
JACC Cardiovasc Interv
|
2017
|
0.75
|
|
57
|
The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related?: Insights From a Meta-Analysis.
|
JACC Cardiovasc Interv
|
2016
|
0.75
|
|
58
|
The Hidden Players.
|
JACC Cardiovasc Interv
|
2016
|
0.75
|
|
59
|
Drug-eluting stents versus bare-metal stents for saphenous vein graft revascularisation: A meta-analysis of randomised trials.
|
EuroIntervention
|
2017
|
0.75
|
|
60
|
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
|
J Hypertens
|
2017
|
0.75
|
|
61
|
Bare metal stent thrombosis 13 years after implantation.
|
Cardiovasc Revasc Med
|
2009
|
0.75
|
|
62
|
Clopidogrel and coronary stents: risks and benefits.
|
Curr Atheroscler Rep
|
2008
|
0.75
|